FDA Guides On Generic Development During COVID-19

Q&A Guidance Document Addresses Common Queries From ANDA Applicants

 
• By Dave Wallace
  
COVID Question Mark Coronavirus
The FDA has answered ANDA developers’ questions around COVID-19 • Source: Shutterstock

More from Regulation

More from Policy & Regulation